Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

April 23, 2018 Issue

09617-cover-opener.jpg

April 23, 2018 Cover

Volume 96, Issue 17

Change in the finished-dose generic drug business is creating openings, albeit modest ones, for pharmaceutical ingredient makers

Cover:A photo of different pills spilling onto a surface.

Credit: Shutterstock

Full Article
Volume 96 | Issue 17

All Issues

Quote of the Week

“You can’t say it’s renewable unless it meets the carbon-14 test.”

Ronald Cascone, renewable chemicals consultant , Nexant

Generics

Turmoil in generics brings opportunity for fine chemicals firms

Change in the finished-dose generic drug business is creating openings, albeit modest ones, for pharmaceutical ingredient makers

  • Novartis and Berkeley researchers team up to tackle the industry’s toughest drug targets

    The collaborators hope new advances in chemical biology could open up the human proteome

  • Louisiana State University’s ChemDemo program brings chemistry to the community

    Outreach program has dispatched more than 15,000 college students to do hands-on activities in K–12 classrooms

  • Periodic graphics: How is plastic recycled?

    Chemical educator and Compound Interest blogger Andy Brunning explains what happens (or doesn’t) after you throw those bottles and bags in the recycle bin

ADVERTISEMENT
image name
Protein Folding

Pressure control helps NMR analyze protein as it folds

Detailed views could find use in studying folding-related diseases

ADVERTISEMENT
ADVERTISEMENT